Misc Vaccines - Anthrax
The Missing Fax
Plague
Advice to Commanders
Vaccination Ammendment
Experiment Results
SPVA - Awareness of Symptoms
FDA Clearance for PB
PB (NAPS) vs Sarin and Soman
On 16 August 1990 a meeting was held at the Centre for Applied Microbiology & Research (CAMR) in Porton Down. The aim of the meeting was to discuss the availability of vaccines and immunisations to the MoD. Points minuted during the meeting include:
On 21 December 1990 a fax was sent from the National Institute for Biological Standards and Control to the Department of Health in Whitehall. The fax related to Anthrax/Pertussis and warned that in animal trials the condition of the animals deteriorated when the two agents were combined. Note that this was at the single human dose level and we were to be given a double dose. It is claimed that this fax went missing and was never read; the truth of what happened will probably never be known.
On 2 January 1991 a meeting was held in Whitehall to discuss providing UK service personnel with protection against Plague. Decisions taken in the meeting include:
On 8 February 1991 a memo was sent to the CDE Porton Down requesting advice. Points raised in the memo include:
On 12 February 1991 a signal was sent out advising that:
In October 1997 a paper was published by the MoD detailing the outcome of giving the Anthrax/Pertussis combination to service personnel, or to put it another way, the results of the experiment!
What is of great interest is the fact that one of the deductions of the experiment is to state that the effect of the vaccination on personnel was very much dependent on both the individual's genetic make up and the number of external stressors affecting that individual at the time. This may go a long way towards explaining why some are ill, some are not and, those who are ill are ill to different degrees and in subtly different ways (Page 7 Central Paragraph)
In June 1997 the SPVA issued guidelines to it's staff covering how claims for illness associated with the Gulf War should be handled. Although an attempt was made to redact the document, it is still quite legible and you can clearly see the type of symptoms suffered by Gulf War veterans (Para 40654)
In a posting last updated in 2009 the FDA explains how it has given clearance for the use of PB as an effective agent against nerve agent - but only one nerve agent; SOMAN (Para 1).
Additionally, the listing states that, in the 1991 Gulf War, PB was used as an "investigational new drug" (Para 11). More proof of experimantation.
PB (NAPS) was meant to reduce the effects of Soman. Iraq did not have Soman but did have Sarin. PB reduces the chances of an effective recovery from Sarin poisoning, A further example of experimentation.